Blog

Wondering why we haven’t posted in a while?

Our blog has moved to a different location.
Visit http://blog.basecase.net to check out our latest blog posts.

Why should you choose BaseCase?

While BaseCase offers a unique product, it’s not without competition. CMS (Content Management System) providers promise to manage commercial content for the sales force, while offering Closed Loop Marketing, both important aspects of our offering. On the market access side, creative agencies and HEOR consultancies offer custom apps to be...

6 weeks to create a customer engagement app?

How quickly can you create a customer engagement app for the iPad? When I ask this question to a potential client, they tend to say it takes around six months. Typically this involves using a creative agency to design and program a presentation for market access, medical affairs or the ...

No other CLM platform lets you create iPad apps

BaseCase Interactive offers app development and distribution in a single platform Using BaseCase Interactive to both create and distribute marketing content saves time, and it helps you to stay flexible. Benefits include launching your product earlier and ensuring your sales reps always use up-to-date messages with your customers. How does ...

Show the value of market access

Success in market access these days is almost never as black and white as ‘access or no access’. After the national authorities give their approval, there’s a very diverse landscape of local and regional payers that need convincing to ensure market uptake. Market access managers sometimes struggle to demonstrate the va...

A new market access strategy to offer budget holders value

In recent years, we’ve seen the emergence of new strategies to improve engagement with payers. It’s a sign of the rising importance of market access in the pharmaceutical industry. It used to be that medical affairs and market access teams were required to show the safety and clinical effi...

Using HEOR to improve market access for orphan drugs

A recent report from technology market research company BCC predicted that the total global market for orphan drugs would rise from $82.6 billion in 2011 to $112 billion by 2015. Until legislation such as the U.S. Orphan Drug Act of 1983 was passed, treatments for rare diseases were not profitable enough to be pursued ...

Communicating HEOR to colleagues

Every time I talk to health economists or market access managers about the commercial outlook, I hear a similar story: customer engagement at the local level is becoming more difficult. To our clients, the attraction of BaseCase is that it helps encourage adoption at the local level, by helping to ...